NewGenIvf Group (NASDAQ:NIVF) Major Shareholder Financial Lp Hrt Sells 85,317 Shares

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt sold 85,317 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $0.80, for a total value of $68,253.60. Following the sale, the insider owned 54,561 shares of the company’s stock, valued at approximately $43,648.80. This represents a 60.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Tuesday, May 26th, Financial Lp Hrt purchased 27,993 shares of NewGenIvf Group stock. The stock was acquired at an average price of $0.92 per share, with a total value of $25,753.56.
• On Friday, May 22nd, Financial Lp Hrt purchased 137,541 shares of NewGenIvf Group stock. The stock was acquired at an average price of $0.99 per share, with a total value of $136,165.59.

NewGenIvf Group Stock Up 21.2%

NASDAQ NIVF opened at $1.03 on Friday. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. NewGenIvf Group Limited has a 1-year low of $0.72 and a 1-year high of $1,839.00. The company has a 50 day moving average of $1.66 and a 200-day moving average of $6.74.

NewGenIvf Group (NASDAQ:NIVF) last released its quarterly earnings results on Tuesday, March 31st. The company reported ($287.24) earnings per share for the quarter. The firm had revenue of $1.42 million for the quarter. As a group, equities research analysts expect that NewGenIvf Group Limited will post 4.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.